000 01649 a2200421 4500
005 20250514022841.0
264 0 _c20020402
008 200204s 0 0 eng d
022 _a0007-1188
024 7 _a10.1038/sj.bjp.0704474
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCroxtall, Jamie D
245 0 0 _aDifferent glucocorticoids vary in their genomic and non-genomic mechanism of action in A549 cells.
_h[electronic resource]
260 _bBritish journal of pharmacology
_cJan 2002
300 _a511-9 p.
_bdigital
500 _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aArachidonic Acid
_xantagonists & inhibitors
650 0 4 _aCell Division
_xdrug effects
650 0 4 _aCyclooxygenase 2
650 0 4 _aDexamethasone
_xpharmacology
650 0 4 _aDinoprostone
_xantagonists & inhibitors
650 0 4 _aEnzyme Activation
_xdrug effects
650 0 4 _aGene Expression Regulation, Enzymologic
_xdrug effects
650 0 4 _aGlucocorticoids
_xpharmacology
650 0 4 _aHumans
650 0 4 _aIsoenzymes
_xantagonists & inhibitors
650 0 4 _aMembrane Proteins
650 0 4 _aPhospholipases A
_xmetabolism
650 0 4 _aProstaglandin-Endoperoxide Synthases
_xbiosynthesis
650 0 4 _aSignal Transduction
_xdrug effects
650 0 4 _aTumor Cells, Cultured
_xcytology
700 1 _avan Hal, Peter Th W
700 1 _aChoudhury, Qam
700 1 _aGilroy, Derek W
700 1 _aFlower, Rod J
773 0 _tBritish journal of pharmacology
_gvol. 135
_gno. 2
_gp. 511-9
856 4 0 _uhttps://doi.org/10.1038/sj.bjp.0704474
_zAvailable from publisher's website
999 _c11725320
_d11725320